A One-Month Advanced Glycation End Products—Restricted Diet Improves CML, RAGE, Metabolic and Inflammatory Profile in Patients with End-Stage Renal Disease Undergoing Haemodialysis
Authors:
- Adamantia AroniAAAdamantia Aroni
- Paraskevi DetopoulouParaskevi Detopoulou
- Demetrios PresvelosDPDemetrios Presvelos
- Eirini KostopoulouEirini Kostopoulou
- Anastasios IoannidisAIAnastasios Ioannidis
- George I. PanoutsopoulosGPGeorge I. Panoutsopoulos
- Sofia ZygaSofia Zyga
- Georgios KosmidisGKGeorgios Kosmidis
- Bessie E. SpiliotisBessie E. Spiliotis
- Andrea Paola Rojas GilAndrea Paola Rojas Gil
Open Access
- 15 August 2024
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (16) , 8893
Abstract
Exogenous and endogenous advanced glycation end products (AGEs) contribute to the pathogenesis and progression of renal disease. This is a one-month controlled dietary counseling trial that restricts nutritional AGEs in patients with end-stage renal disease (ESRD) undergoing haemodialysis (n = 22 participants in the intervention and n = 20 participants in the control group). Haematological, biochemical markers, the soluble form of the receptor for AGEs (sRAGE), and carboxymethyl lysine (CML) were measured at baseline and at follow-up. Mononuclear cells were isolated and the protein expression of RAGE and the inflammatory marker COX-2 was measured using Western immunoblotting. The intervention group presented a lower increase in CML compared to the control group (12.39% median change in the intervention vs. 69.34% in the control group, p = 0.013), while RAGE (% mean change −56.54 in the intervention vs. 46.51 in the control group, p < 0.001) and COX-2 (% mean change −37.76 in the intervention vs. 0.27 in the control group, p < 0.001) were reduced compared to the control group. sRAGE was reduced in both groups. In addition, HbA1c (at two months), total cholesterol, and triglycerides were reduced in the intervention versus the control group. The adoption of healthy cooking methods deserves further research as a possible way of modulating inflammatory markers in patients with CKD.Keywords
This publication has 51 references indexed in Scilit:
- κ-Carrageenan inhibits the formation of advanced glycation end products in cakes: Inhibition mechanism, cake characteristics, and sensory evaluationFood Chemistry, 2023
- Inflammation level in type 2 diabetes is associated with dietary advanced glycation end products, Mediterranean diet adherence and oxidative balance score: A pathway analysisJournal of Diabetes and its Complications, 2022
- Suppression of COX-2/PGE2 levels by carbazole-linked triazoles via modulating methylglyoxal-AGEs and glucose-AGEs – induced ROS/NF-κB signaling in monocytesCellular Signalling, 2022
- Diet-Derived Advanced Glycation End Products (dAGEs) Induce Proinflammatory Cytokine Expression in Cardiac and Renal Tissues of Experimental Mice: Protective Effect of CurcuminCardiovascular Toxicology, 2021
- Hemodialysis biomarkers: total advanced glycation end products (AGEs) against oxidized human serum albumin (HSAox)Acta Diabetologica, 2019
- Comparative evaluation of three different ELISA assays and HPLC-ESI-ITMS/MS for the analysis of N ε -carboxymethyl lysine in food samplesFood Chemistry, 2018
- Advanced Glycation End Products (AGE) and Diabetes: Cause, Effect, or Both?Current Diabetes Reports, 2013
- The association of receptor of advanced glycated end products and inflammatory mediators contributes to endothelial dysfunction in a prospective study of acute kidney injury patients with sepsisMolecular and Cellular Biochemistry, 2011
- Monocytes from type 2 diabetic patients have a pro-inflammatory profileDiabetes Research and Clinical Practice, 2007
- Detection of Noncarboxymethyllysine and Carboxymethyllysine Advanced Glycation End Products (AGE) in Serum of Diabetic PatientsMolecular Medicine, 1999